Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Unit of Dietetics and Sports Medicine, Department of Experimental Medicine, Section of Human Physiology, Università degli Studi della Campania "Luigi Vanvitelli", 80100 Naples, Italy.
Nutrients. 2022 Oct 18;14(20):4361. doi: 10.3390/nu14204361.
Obesity is a multifactorial disease strongly associated with insulin resistance and/or type 2 diabetes mellitus. Correct nutrition represents a valid strategy to fight these dysmetabolic pathologies responsible for numerous diseases, including inflammatory and cardiovascular ones. Medical nutrition therapy, including a Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLKCD), is the first-line treatment for prediabetes/diabetes and overweight/obesity. Eighty patients (forty women and forty men) affected by overweight/obesity and type 2 diabetes mellitus or impaired glucose tolerance or impaired fasting glucose (51 (ys) ± 1.75; BMI (kg/m) 33.08 ± 1.93; HA1c (%): 6.8% ± 0.25) were enrolled at the University Service of Diet Therapy, Diabetology and Metabolic Diseases, Policlinico Riuniti Hospital of Foggia, and subjected to a very-low-calorie Mediterranean diet and a very-low-calorie ketogenic Mediterranean diet for thirty days. Both diets result in a marked decrease in body weight (kg) and BMI (kg/m). At the same time, only the very-low-calories ketogenic Mediterranean diet reduced waist and hip circumferences. Both diets helped reduce fat mass, but a major loss was achieved in a very low-calorie ketogenic Mediterranean diet. Among gluco-metabolic parameters, only the very-low-calorie ketogenic Mediterranean diet group showed a significant decrease in fasting blood glucose and HbA1c, insulin, C-peptide total cholesterol, LDL, and triglycerides. The results of our study seem to show that the very-low-calorie ketogenic Mediterranean diet is a good strategy to improve rapidly metabolic, anthropometric, and body composition parameters in patients with prediabetes or diabetes and overweight/obesity.
肥胖是一种多因素疾病,与胰岛素抵抗和/或 2 型糖尿病密切相关。正确的营养是对抗这些导致许多疾病(包括炎症和心血管疾病)的代谢紊乱的有效策略。医学营养治疗,包括地中海饮食(MD)和极低卡路里生酮饮食(VLKCD),是治疗糖尿病前期/糖尿病和超重/肥胖的一线治疗方法。
80 名超重/肥胖和 2 型糖尿病或糖耐量受损或空腹血糖受损的患者(40 名女性和 40 名男性;年龄 51(岁)±1.75;BMI(kg/m²)33.08 ± 1.93;HA1c(%):6.8% ± 0.25)在福贾联合诊所的饮食治疗、糖尿病和代谢疾病大学服务处登记,并接受 30 天的极低卡路里地中海饮食和极低卡路里生酮地中海饮食。两种饮食都显著降低了体重(kg)和 BMI(kg/m²)。与此同时,只有极低卡路里生酮地中海饮食降低了腰围和臀围。两种饮食都有助于减少脂肪量,但在极低卡路里生酮地中海饮食中,脂肪量的减少更为明显。在糖代谢参数中,只有极低卡路里生酮地中海饮食组空腹血糖和 HbA1c、胰岛素、总胆固醇、LDL 和甘油三酯显著降低。
我们的研究结果似乎表明,极低卡路里生酮地中海饮食是一种很好的策略,可以快速改善糖尿病前期或糖尿病和超重/肥胖患者的代谢、人体测量和身体成分参数。